Effects of Nigerian Honey on Blood Glucose and Lipids in Patients with Diabetes

Effects of Nigerian Honey on Hyperglycemia and Lipid Abnormalities in Patients with Type 2 Diabetes Mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201904874997298

Enrollment

Registered

2019-04-18

Start date

2019-05-20

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Honey group

Control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with fasting blood glucose of >/= 126 mg/dL Patients on a biguanide and a sulphonylurea Willingness to comply with the demands of the experimental protocol

Exclusion criteria

Exclusion criteria: Patients who are insulin dependent Patients with malignancy/cancer and other serious underlying disease conditions Patients who are taking certain kinds of medications such as cytotoxic, immunosuppressive, immunomodulatory, stimulating, performance-enhancing drugs Regular consumption of alcohol or supplements (esipecially antioxidant supplements) Cigarette smokers Patients who are pregnant or lactating Patients with renal or hepatic impairment

Design outcomes

Primary

Measure	Time frame
Serum glucose;Serum total cholesterol;Serum triglycerides;Serum high density lipoprotein cholesterol;Serum low density lipoprotein cholesterol	—

Secondary

Measure	Time frame
Blood pressure;Serum malondialdehyde;Serum total antioxidant status;Serum creatinine;Serum alanine transaminase;Body weight	—

Countries

Nigeria

Contacts

Public ContactMaria Offor

Postgraduate Student

nkeychi4eva@gmail.com+2348066124427

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026